
    
      PRIMARY OBJECTIVE:

      To evaluate the adequacy and efficiency of study protocols for the anticipated, randomized,
      controlled ECASSS study. The primary clinical outcome is organ-failure free days at 28 days,
      with multiple secondary outcomes, including those relevant to function of and compliance with
      the study protocols.
    
  